Prominent cell and gene therapy vendors in 2023

[Image courtesy of catalin/Adobe Stock]

In recent years, the cell and gene therapy market has grown at a rapid clip. The momentum is likely to continue. According to Vision Research Reports, the global cell and gene therapy market size could hit around $42.56 billion by 2030, growing at a CAGR of 39% from 2022 to 2030.

The burgeoning demand in the industry, along with an increasing number of FDA-approved therapies, is also fueling the growth of cell and gene therapy vendors offering tools and services for product development and manufacturing.

The following table includes notable vendors and suppliers active in the call and gene therapy marketplace. This curated selection of companies includes a brief overview of their focus areas.

We have a separate feature focused on companies with prominent cell and gene therapy development efforts.

Company Name Description Notable partnerships Founded He…
Read more
  • 0

Akoya Biosciences hires new chief people officer

The self-proclaimed “spatial biology company” Akoya Biosciences (NSDQ:AKYA) has appointed Marilee Moy as its chief people officer.

Moy has more than three decades of experience in human resources and has worked for several life science companies, including Questcor, Counsyl, Tails Biomedical, Genentech and Johnson & Johnson.

Akoya, which went public last year, had raised more than $83 million in funding.

The company was founded in 2015 to commercialize technology developed at Stanford University that enables ultra-high multiplexed analysis for biomarker discovery.

Marilee Moy

Akoya specializes in spatial phenotyping, which provides insights into cell-cell interactions within tissue.

The company says its PhenoCycler-Fusion system can map one million cells in 10 minutes.

“As a member of our senior leadership team, I am particularly interested in the development of the com…

Read more
  • 0